Page 90 - 2019_03-Haematologica-web

P. Lin et al.
effect of pharmacological inhibition of
Nrf2. PLoS One. 2017;12(5):e0177227.
39. Hong F, Freeman ML, Liebler DC. Identification of sensor cysteines in human Keap1 modified by the cancer chemopre- ventive agent sulforaphane. Chem Res
Toxicol. 2005;18(12):1917-1926.
40. Shah NM, Zaitseva L, Bowles KM, MacEwan DJ, Rushworth SA. NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML sur- vival. Cell Death Differ. 2015;22(4):654-
664.
41. Cai H, Scott E, Kholghi A, et al. Cancer
chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci Transl Med. 2015;7(298):298ra117.
42. Cole SP. Targeting multidrug resistance pro- tein 1 (MRP1, ABCC1): past, present, and
future. Annu Rev Pharmacol Toxicol.
2014;54:95-117.
43. Checker R, Gambhir L, Sharma D, Kumar
M, Sandur SK. Plumbagin induces apopto- sis in lymphoma cells via oxidative stress mediated glutathionylation and inhibition of mitogen-activated protein kinase phos- phatases (MKP1/2). Cancer Lett. 2015;357(1):265-278.
44. Keyse SM, Emslie EA. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature. 1992;359(6396):644-647.
45. Wang H, Liu X, Long M, et al. NRF2 activa- tion by antioxidant antidiabetic agents accelerates tumor metastasis. Sci Transl Med. 2016;8(334):334ra351.
46. Tschop MH, Stumvoll M, Ristow M. Opposing Effects of Antidiabetic Interventions on Malignant Growth and Metastasis. Cell Metab. 2016;23(6):959-960.
47. Mar BG, Chu SH, Kahn JD, et al. SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia. Blood. 2017;130(24):2631-2641.
48. Gollner S, Oellerich T, Agrawal-Singh S, et al. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia. Nat Med. 2017;23(1):69-78.
49. Palau A, Mallo M, Palomo L, et al. Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemia. Genes Chromosomes Cancer. 2017;56(3):243-252.
50. Medyouf H, Mossner M, Jann JC, et al. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell. 2014;14(6):824-837.
496
haematologica | 2019; 104(3)